CM
CME
Quarter ended Dec 31, 2023 · FY2023 Q4

CME Group (CME) Revenue — Quarter Ended Dec 31, 2023

Revenue for the reported quarter increased compared with the immediately preceding quarter. It also rose relative to the same period one year earlier.

Key takeaway

Quarter ended Dec 31, 2023 · FY2023 Q4

Revenue for the reported quarter increased compared with the immediately preceding quarter. It also rose relative to the same period one year earlier.

Financial snapshot

Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.

Quarter revenue

$1.4B

Revenue reported for this quarter.

Quarter-over-quarter

+7.6%

Change from the immediately preceding quarter.

Year-over-year

+19.2%

Change from the comparable year-ago quarter.

Trailing four quarters

$5.6B

Sum of the latest four reported quarters.

Quarterly revenue trend

The latest four reported quarters with year-over-year comparisons.

Period endedRevenueYear-over-year change
Mar 31, 2023$1.4B+7.1%
Jun 30, 2023$1.4B+9.9%
Sep 30, 2023$1.3B+9.0%
Dec 31, 2023$1.4B+19.2%

Revenue performance

The reported revenue reflects a sequential improvement, reversing the decline seen in the prior quarter. The growth versus the year-ago period was notably stronger than the quarter-over-quarter change.

Quarterly comparison

Revenue in the reported quarter was higher than both the immediately preceding quarter and the same quarter one year earlier. The year-over-year increase was more pronounced than the sequential gain.

What to watch

The sequential revenue recovery merits attention given the dip in the prior quarter.